The impact of complete lymph node dissection for lung cancer on the postoperative course.

HANDLE オープンアクセス

この論文をさがす

抄録

The role of lymph node dissection (LND) for non-small cell lung cancers (NSCLCs) remains controversial. LND adds little morbidity to a pulmonary resection for NSCLC, although it requires an additional 15 to 20 minutes of operative time. Four prospective randomized trials have been performed to compare lymph node sampling and LND; 3 trials showed no difference in survival and 1 showed survival benefit of LND. It is recommended that all patients with resectable NSCLC undergo LND because the procedure provides patients with the most accurate staging and the opportunity for effective adjuvant therapy.

収録刊行物

詳細情報 詳細情報について

  • CRID
    1050282810708652928
  • NII論文ID
    120004057180
  • NII書誌ID
    AA12016910
  • ISSN
    15474127
  • HANDLE
    2433/155458
  • 本文言語コード
    en
  • 資料種別
    journal article
  • データソース種別
    • IRDB
    • CiNii Articles

問題の指摘

ページトップへ